Table 1.
Characteristics of the 100 included patients
Characteristic | Value |
---|---|
Age (years) | |
Mean ± SD | 68.75 ± 7.6 |
Median (range) | 70.44 (47.36–85.82) |
Administered activity (MBq) | |
Mean ± SD | 338.02 ± 33.31 |
Median (range) | 334 (200–412) |
Gleason scorea | |
Mean ± SD | 7.5 ± 1.01 |
Median (range) | 7 (5–10) |
PSA level at PET (ng/ml) | |
Mean ± SD | 3.36 ± 6.11 |
Median (range) | 1.34 (0.04–41.3) |
Prior therapies, n (%) | |
Prostatectomy | 92 (92) |
Radiation beam therapy to prostate bed | 45 (45) |
Androgen-deprivation therapy | 27 (27) |
SD standard deviation, PSA prostate-specific antigen
aIn 76 patients; data from 24 patients missing